Clinical or subclinical hyperparathyroidism is one of the most common endocrine disorders.
Excessive secretion of parathyroid hormone is most frequently caused by an adenoma of ≥…

Background: The American Thyroid Association (ATA), the European Association of Nuclear
Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and …

The present guidelines were issued by the Parathyroid Task Group of the European Association
of Nuclear Medicine. The main focus was imaging of primary hyperparathyroidism. Dual-…

Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …

This study is a retrospective analysis of 124 differentiated thyroid cancer patients who underwent
dosimetric evaluation using MIRD methodology over a period of 15 y. The objectives of …

PURPOSE: Radioembolization (RE) using 90 Y-microspheres is an effective and safe treatment
for patients with unresectable liver malignancies. Radiation-induced liver disease (RILD…

Therapy with 90Y-microspheres is emerging as a mainstream treatment modality in the
management of patients with primary and metastatic liver cancer (1, 2). The technique involves …

Objective To discuss the basic concepts involved in the development of yttrium 90 (Y-90)
microsphere selective internal radiation treatment and review the clinical data pertaining to its …

Background Treatment records and follow-up data on 40 patients with primary and
metastatic liver malignancies who underwent a single whole-liver treatment with Y-90 resin …

This Phase I/II radioimmunotherapy study was carried out to determine the maximum tolerated
dose (MTD) and therapeutic potential of 131I-G250. Thirty-three patients with measurable …